OKT3 and hepatitis C: defining the risks.
Rosen
H R
HR
Martin
P
P
D006526:Hepatitis C / Q000209:etiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016031:Liver Transplantation / Q000009:adverse effects*; D016853:Muromonab-CD3 / Q000009:adverse effects*; D012008:Recurrence
D007166:Immunosuppressive Agents; D016853:Muromonab-CD3